{"url_path":"/sec/mens/10-k/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1954488/0001213900-26-057073-index.html","accession_number":"0001213900-26-057073","cik":"0001954488","ticker":"MENS","issuer_name":"Jyong Biotech Ltd.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1954488/0001213900-26-057073-index.html","primary_entity_key":"0001954488","primary_entity_name":"Jyong Biotech Ltd."},"word_count":931,"has_tables":true,"body_markdown":"**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**WASHINGTON, D.C. 20549**\n\n \n\n**FORM 20-F**\n\n \n\n**(Mark One)**\n\n☐ **REGISTRATION\nSTATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\n**OR**\n\n \n\n☒ **ANNUAL\nREPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\n**For the fiscal year ended December 31, 2025**\n\n \n\n**OR**\n\n \n\n☐ **TRANSITION\nREPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\n**For the transition period from _________to_________**\n\n \n\n**OR**\n\n \n\n☐ **SHELL\nCOMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\n**Date of event requiring this shell company report:__________**\n\n \n\n**For the transition period from________to_________**\n\n \n\n**Commission file number: 001-42445**\n\n \n\n**Jyong Biotech Ltd.**\n\n**(Exact name of Registrant as specified in its\ncharter)**\n\n \n\n**N/A**\n\n**(Translation of Registrant’s name into\nEnglish)**\n\n \n\n**Cayman Islands**\n\n**(Jurisdiction of incorporation or organization)**\n\n \n\n**23F-3, No. 95, Section 1, Xintai 5th\nRoad,\nXizhi District, New Taipei City,\nTaiwan, 221\nTel: +886-2-2732-5205**\n\n**(Address of principal executive offices)**\n\n \n\n**Wei Zhang, Chief Financial Officer**\n\n**Telephone: +886-2-2732-5205**\n\n**Email address: ir@jyongbio.com**\n\n**23F-3, No. 95, Section 1, Xintai 5th\nRoad,\nXizhi District, New Taipei City, Taiwan, 221\n(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)**\n\n \n\n**Securities registered or to be registered pursuant\nto Section 12(b) of the Act:**\n\n \n\n**Title of each class**   **Trading Symbol(s)**   **Name of each exchange on which registered**\n\n**Ordinary shares, par value US$0.00001 per share**   **MENS**   **The Nasdaq Stock Market LLC**\n\n \n\n**Securities registered or to be registered pursuant\nto Section 12(g) of the Act:**\n\n \n\n**None**\n\n**(Title of Class)**\n\n \n\n**Securities for which there is a reporting obligation\npursuant to Section 15(d) of the Act:**\n\n \n\n**None**\n\n**(Title of Class)**\n\n \n\n \n\n \n\nIndicate the number of outstanding shares of each of the issuer’s\nclasses of capital or common stock as of the close of the period covered by the annual report:\n\n \n\nAs of December 31, 2025, there were 76,027,667 ordinary shares issued\nand outstanding, par value US$0.00001 per share.\n\n \n\nIndicate by check mark if the registrant is a well-known seasoned issuer,\nas defined in Rule 405 of the Securities Act Yes ☐ No ☒\n\n \n\nIf this report is an annual or transition report, indicate by check\nmark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Yes ☐ No ☒\n\n \n\nIndicate by check mark whether the registrant (1) has filed all reports\nrequired to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter\nperiod that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.\nYes ☒ No ☐\n\n \n\nIndicate by check mark whether the registrant has submitted electronically\nevery Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the\npreceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐\n\n \n\nIndicate by check mark whether the registrant is a large accelerated\nfiler, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of “large accelerated filer,\n“accelerated filer” and “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\n \n\nLarge accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Emerging growth company ☒\n\n \n\nIf an emerging growth company that prepares its financial statements\nin accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying\nwith any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\n \n\n \n†\nThe term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.\n\n \n\nIndicate by check mark whether the registrant has filed a report on\nand attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section\n404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐\n\n \n\nIf securities are registered pursuant to Section 12(b) of the Act,\nindicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to\npreviously issued financial statements. ☐\n\n \n\nIndicate by check mark whether any of those error corrections are restatements\nthat required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during\nthe relevant recovery period pursuant to §240.10D-1(b). ☐\n\n \n\nIndicate by check mark which basis of accounting the registrant has\nused to prepare the financial statements included in this filing:\n\n \n\nU.S. GAAP ☒   International Financial Reporting Standards as issued\n\nby the International Accounting Standards Board ☐   Other ☐\n\n \n\nIf “Other” has been checked in response to the previous\nquestion, indicate by check mark which financial statement item the registrant has elected to follow: Item 17 ☐ Item\n18 ☐\n\n \n\nIf this is an annual report, indicate by check mark whether the registrant\nis a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒\n\n \n\n(APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING\nTHE PAST FIVE YEARS)\n\n \n\nIndicate by check mark whether the registrant has filed all documents\nand reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of\nsecurities under a plan confirmed by a court. ☐ Yes ☐ No\n\n \n\n \n\n \n\n \n\n \n\n**TABLE OF CONTENTS**\n\n \n\n[INTRODUCTION](#a_001)\nii\n\n \n \n\n[PART I](#a_002)\n1"}